The iCAN groups KIDS Albania and KIDS Bari, with the support of CVBF and TEDDY Network, have created a brand-new serious game: My Clinical Trial Center (My CTC) to share clinical research learnings. The game in fact aims at explaining to children in a fun way what clinical trials are, how they work and why they are [...]
The European Commission has launched a manifesto to maximise the accessibility of research results in the fight against COVID-19. The manifesto provides guiding principles for beneficiaries of EU research grants for coronavirus prevention, testing, treatment and vaccination to ensure that their research results will be accessible for all and guarantee a return on public investment. [...]
The University of Parma will organise the II Level Master in Preclinical and Clinical Research for the Academic Year 2020/2021. The courses will start in December 2020 and the whole duration of the Master will be 12 months. The deadline for the registration is 23 October 2020. The program of the Master is available at [...]
The Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM) of the National Research Council (CNR) in collaboration with the Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) organised the webinar entitled “Paediatric Diseases: research, biodrugs and territory”, held online on the 29th of September 2020.The webinar has been organised in the framework of the Biotech Week, [...]
The European Commission is launching a new strategy to improve and accelerate patients’ access to safe and affordable medicines and to support innovation in the EU pharmaceutical industry, addressing mainly: the life cycle of medicines from R&D to authorisation and patient access how to put scientific and technological advances into practice how to fill market [...]
We are glad to inform you that Consorzio per Valutazioni Biologiche e Farmacologiche will provide its contribution in the fight against COVID-19 emergency. It was recently been entrusted by UPMC - University of Pittsburgh Medical Center with the two studies on COVID-19 which aim to test two vaccines in the form of a patch (protein [...]
EMA has now set up an infrastructure to support the monitoring of the efficacy and safety of COVID-19 treatments and vaccines when used in day-to-day clinical practice. This is underpinned by three contracts for observational research that EMA has signed with academic and private partners over recent months, to be ready to effectively monitor medicines [...]
In the framework the c4c IMI2 funded project (pan European paediatric clinical trials network) cASPerCF study will be carried out. The study is being led and coordinated by the MRC Centre for Medical Mycology at the University of Exeter, United Kingdom, in collaboration with the Children’s Hospital Bambino Gesù in Rome, Italy, which acts as [...]
Since 2002 CVBF has been acting as Sponsor and Clinical Research Organisation (CRO) involved in clinical trial execution and it is currently ready to provide its expertise in clinical trials at national and international level, with a specific attention to the field of paediatric and rare diseases. Another important goal has been just reached by [...]
The European Medicines Agency (EMA) released an Expert Group Recommendation on the content of Lay Summaries of clinical study results from commercial and non-commercial sponsors. The upcoming Clinical Trial Regulation, in fact, requires the development and dissemination of Lay Summaries of clinical study results from commercial and non-commercial sponsors. However, there is no guidance for [...]
